Clearpoint Neuro Profit Margin vs. Price To Sales

CLPT Stock  USD 18.32  0.06  0.33%   
Considering Clearpoint Neuro's profitability and operating efficiency indicators, Clearpoint Neuro may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Clearpoint Neuro's ability to earn profits and add value for shareholders.

Clearpoint Neuro Net Profit Margin

(0.87)

At this time, Clearpoint Neuro's Price To Sales Ratio is comparatively stable compared to the past year. EV To Sales is likely to gain to 10.20 in 2025, whereas Days Of Sales Outstanding is likely to drop 42.97 in 2025. At this time, Clearpoint Neuro's Total Other Income Expense Net is comparatively stable compared to the past year. Interest Income is likely to gain to about 624.8 K in 2025, despite the fact that Net Loss is likely to grow to (18.9 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.750.65
Fairly Up
Slightly volatile
For Clearpoint Neuro profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Clearpoint Neuro to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Clearpoint Neuro utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Clearpoint Neuro's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Clearpoint Neuro over time as well as its relative position and ranking within its peers.
  

Clearpoint Neuro's Revenue Breakdown by Earning Segment

Check out Trending Equities.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearpoint Neuro. If investors know Clearpoint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearpoint Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.69)
Revenue Per Share
1.158
Quarterly Revenue Growth
0.41
Return On Assets
(0.28)
Return On Equity
(0.68)
The market value of Clearpoint Neuro is measured differently than its book value, which is the value of Clearpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Clearpoint Neuro's value that differs from its market value or its book value, called intrinsic value, which is Clearpoint Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearpoint Neuro's market value can be influenced by many factors that don't directly affect Clearpoint Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearpoint Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearpoint Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearpoint Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Clearpoint Neuro Price To Sales vs. Profit Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Clearpoint Neuro's current stock value. Our valuation model uses many indicators to compare Clearpoint Neuro value to that of its competitors to determine the firm's financial worth.
Clearpoint Neuro is rated below average in profit margin category among its peers. It is rated second in price to sales category among its peers . At this time, Clearpoint Neuro's Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Clearpoint Neuro by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Clearpoint Price To Sales vs. Profit Margin

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Clearpoint Neuro

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
(0.60) %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Clearpoint Neuro

P/S

 = 

MV Per Share

Revenue Per Share

 = 
16.61 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Clearpoint Price To Sales Comparison

Clearpoint Neuro is currently under evaluation in price to sales category among its peers.

Clearpoint Neuro Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Clearpoint Neuro, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Clearpoint Neuro will eventually generate negative long term returns. The profitability progress is the general direction of Clearpoint Neuro's change in net profit over the period of time. It can combine multiple indicators of Clearpoint Neuro, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-20.2 M-19.2 M
Income Before Tax-19.9 M-18.9 M
Total Other Income Expense Net321.3 K329.7 K
Net Loss-19.9 M-18.9 M
Income Tax Expense1.2 M1.1 M
Interest Income443.9 K624.8 K
Net Loss-14.8 M-14.1 M
Net Interest Income435.9 K457.6 K
Net Loss-19.7 M-18.7 M
Non Operating Income Net Other-19.8 K-18.8 K
Change To Netincome4.6 M4.8 M
Net Loss(0.81)(0.85)
Income Quality 0.71  1.02 
Net Income Per E B T 1.16  1.26 

Clearpoint Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Clearpoint Neuro. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Clearpoint Neuro position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Clearpoint Neuro's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Clearpoint Neuro without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Use Investing Themes to Complement your Clearpoint Neuro position

In addition to having Clearpoint Neuro in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Emerging Markets Funds Thematic Idea Now

Emerging Markets Funds
Emerging Markets Funds Theme
Fund or Etfs that invest in markets of developing countries. The Emerging Markets Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.